Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential
International Immunopharmacology · 2026-09 · 185 · 117005
DOI: 10.1016/j.intimp.2026.117005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-09. Verfasst von Yiran Fei und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province,…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Cellular Senescence, Fertility Preservation. Die Arbeit nennt 173 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Cervical cancer is a major global health concern, especially among women of reproductive age, where standard treatments often compromise fertility. Cellular senescence has a dual role in cervical cancer, acting as both a tumor suppressor and promoter through the senescence-associated secretory phenotype (SASP). Human Papillomavirus (HPV) infection, DNA damage, and oxidative stress trigger senescence, leading to SASP-mediated inflammation, tumor progression, and therapy resistance. Targeting senescence offers promising therapeutic opportunities. Senolytics selectively eliminate senescent cells, while senostatics suppress the SASP, improving the tumor microenvironment and enhancing traditional therapies. Telomerase reactivation and epigenetic modulation represent additional strategies to modulate senescence-associated phenotypes. Fertility-preserving treatments, such as radical trachelectomy, combined with senescence-targeting therapies, can expand options for reproductive-age patients, minimizing oncologic risks while maintaining reproductive potential. This review highlights the mechanisms of senescence in cervical cancer and explores novel pathways to target senescent cells, focusing on fertility preservation. Incorporating senescence-targeting strategies with conventional and fertility-sparing treatments may care for young patients, balancing oncologic efficacy with quality of life. Future research and clinical trials are essential to validate these approaches and optimize protocols for widespread clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, China.
- Department of Thoracic Surgery, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou, Jiangsu Province, China.
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, China. Electronic address: 20173626@zcmu.edu.cn.
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, China. Electronic address: zhouqun51@qq.com.
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, China. Electronic address: zhangzhezhong@zcmu.edu.cn.
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Fei, Y., Mao, Y., Cai, W., Huang, L., He, Y., Zhou, Q., & Zhang, Z. (2026). Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential. International Immunopharmacology, 185, 117005. https://doi.org/10.1016/j.intimp.2026.117005
Vancouver
Fei Y, Mao Y, Cai W, Huang L, He Y, Zhou Q, et al. Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential. International Immunopharmacology. 2026;185:117005. doi:10.1016/j.intimp.2026.117005
BibTeX
@article{Fei2026,
author = {Fei, Yiran and Mao, Yiming and Cai, Wenyu and Huang, Liquan and He, Yibo and Zhou, Qun and Zhang, Zhezhong},
title = {Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential},
journal = {International Immunopharmacology},
year = {2026},
volume = {185},
pages = {117005},
doi = {10.1016/j.intimp.2026.117005}
}
EUVIMED